Catalog No.
Product Name
Application
Product Information
Citations
-
Phytocannabinoid Derivative
Δ9-THCH is a phytocannabinoid derivative that exhibits structural similarities to established cannabinoids. This compound interacts with the endocannabinoid system, demonstrating potential biological activity relevant to pain modulation and inflammation reduction. Research applications include studies on cannabinoid receptor signaling and the investigation of therapeutic effects in various neurobiological contexts. -
Cannabinoid Derivative
CHM-FUBIATA is a synthetic cannabinoid derivative that acts primarily on the cannabinoid receptors. It exhibits notable affinity for these receptors, leading to significant alterations in neurotransmitter release and neuroprotection. This compound is utilized in research focused on understanding the pharmacological effects of cannabinoids and their potential therapeutic applications in various neurological disorders. -
Cannabinoid Derivative
PB-22 N-Pentanoic acid-3-carboxyindole metabolite is a significant metabolite of the cannabinoid PB-22, primarily interacting with cannabinoid receptors. This compound exhibits notable activity in modulating cannabinoid signaling pathways and can be utilized in research applications focused on the effects of cannabinoids in neuropharmacology, pain management, and potential therapeutic interventions for various disorders related to the endocannabinoid system. Its study can enhance the understanding of cannabinoid metabolism and its biological implications. -
CB1 Inverse Agonist
MRL-650 is a potent inverse agonist of the CB1 receptor, exhibiting an IC50 of 7.5 nM for CB1, while maintaining a significantly lower affinity for the CB2 receptor at 4100 nM. This compound is orally active and is primarily utilized in research focused on anorexigenic effects. Its selectivity and potency make MRL-650 a valuable tool for investigating the physiological and pharmacological roles of the endocannabinoid system. -
Phytocannabinoid Derivative
iso-Hexahydrocannabinol is a phytocannabinoid derivative that interacts with the endocannabinoid system, primarily targeting cannabinoid receptors. Its unique structure allows it to exhibit biological activities similar to those of other cannabinoids, making it a valuable tool in research exploring the effects of cannabinoids on various physiological processes. Applications include studies on pain management, neuroprotection, and potential therapeutic effects in various medical conditions. -
Phytocannabinoid Derivative
Δ8-iso-THC is a phytocannabinoid derivative that exhibits structural similarities to established cannabinoids. This compound engages cannabinoid receptors, demonstrating potential modulating effects on the endocannabinoid system. Δ8-iso-THC is useful for research into its therapeutic applications, including pain relief, anti-inflammatory effects, and potential neuroprotective properties. Its unique chemical structure makes it a valuable reagent for studying cannabinoid pharmacology and related therapeutic areas. -
Cannabinoid
3-CAF is a synthetic cannabinoid that targets the cannabinoid receptor pathway. This compound exhibits significant activity in modulating cannabinoid receptor signaling, making it a valuable tool for investigating cannabinoid-related biological processes. Its unique 3-carboxylate-indazole structure enhances its selectivity and potency, supporting research applications in pharmacology and neurobiology focused on cannabinoid interactions and their physiological effects. -
Phytocannabinoid Derivative
Cannabigerorcinic acid is a phytocannabinoid derivative that exhibits structural similarities to well-characterized cannabinoids. This compound has demonstrated potential biological activity, making it a valuable asset in the study of cannabinoid mechanisms and their physiological effects. It is particularly relevant for research focusing on the endocannabinoid system, cannabinoid receptor interactions, and potential therapeutic applications in various disorders. -
Cannabinoid Receptor
Cannabiorcol, a cannabinoid receptor modulator, exhibits structural similarities to well-characterized phytocannabinoids. This compound has shown potential in influencing cannabinoid receptor activity, making it a valuable tool in cannabinoid research. Its biological activity is relevant for studies investigating the pharmacological effects of cannabinoids and therapeutic applications in various physiological conditions. -
BB-22 Analog
Methyl-1-(cyclohexylmethyl)-1H-indole-3-carboxylate is an analog of BB-22, characterized by the absence of the quinoline moiety. This compound engages cannabinoid receptors, contributing to its potential as a research tool in pharmacological studies. Its unique structure supports investigations into cannabinoid signaling pathways and may aid in understanding the effects of synthetic cannabinoids. This reagent is suitable for applications in drug discovery and development within the cannabinoid research field. -
Cannabinoid Derivative
5-Fluoro PB-22 5-hydroxyquinoline isomer is a synthetic cannabinoid derivative that acts primarily on cannabinoid receptors. This compound exhibits potent agonistic activity, making it valuable for research into cannabinoid receptor signaling and the pharmacological effects of synthetic cannabinoids. Its use in studies can provide insights into therapeutic applications and the modulation of endocannabinoid system functions. -
THJ-018 Derivative
5-Fluoro THJ is a derivative of the synthetic cannabinoid THJ-018, targeting cannabinoid receptors in the endocannabinoid system. It exhibits biological activity that may influence neurochemical signaling and has potential applications in cannabinoid research, pharmacology, and the study of psychoactive effects. Researchers can utilize this compound to explore the mechanisms underlying cannabinoid receptor activation and its implications in various physiological processes. -
Semisynthetic Cannabinoid
Δ8-THCP (Δ8-Tetrahydrocannabiphorol; n-Heptyl Δ8-THC) is a semisynthetic cannabinoid that primarily targets the CB1 receptor. It has been identified as an analytical reference standard and demonstrates significant affinity for this receptor, contributing to its potential biological activities. This compound is useful in various research applications, particularly in studies focused on cannabinoid receptor interactions and their effects. -
Cannabinoid Receptor Antagonist
CB1 Antagonist 1 is a selective antagonist of the cannabinoid receptor 1 (CB1). It plays a crucial role in research pertaining to metabolic syndrome and obesity, as well as various neuroinflammatory, cognitive, and gastrointestinal disorders. Additionally, it is valuable for investigating cardiovascular conditions, making it a versatile tool in the study of endocannabinoid system-related pathways. -
Stable Isotope
Rimonabant-d10 hydrochloride is a deuterium-labeled derivative of Rimonabant hydrochloride, a selective antagonist of the central cannabinoid receptor (CB1) with a Ki of 1.8 nM. This compound is utilized in studies investigating the role of CB1 receptors in various physiological processes and the development of obesity therapies. Additionally, Rimonabant hydrochloride is known to inhibit Mycobacterial membrane protein Large 3 (MMPL3), making it relevant for research in tuberculosis and related infectious diseases. -
DAGL-α/DAGL-β Inhibitor
LEI105 is a selective and reversible dual inhibitor of diacylglycerol lipase (DAGL)-α and DAGL-β. This compound effectively decreases levels of 2-arachidonoylglycerol in Neuro2A cells, demonstrating its potential to modulate endocannabinoid signaling. Research applications include investigations into the mechanisms underlying obesity, metabolic disorders, and neuroinflammation, as well as studies of cannabinoid receptor-mediated synaptic plasticity in mouse hippocampal slices. -
Active Metabolite of delta 9-Tetrahydrocannabinol
9α,10α-Epoxyhexahydrocannabinol is an active metabolite of delta 9-tetrahydrocannabinol, primarily targeting cannabinoid receptors. This compound exhibits notable anticonvulsant properties, effectively reducing body temperature and prolonging pentobarbital-induced sleep in animal models. Additionally, it has demonstrated protective effects against pentylenetetrazol-induced seizures, making it valuable for research in seizure disorders and cannabinoid pharmacology. -
Active Metabolite of Cannabinol
11-Hydroxy cannabinol is an active metabolite of Cannabinol, primarily targeting cannabinoid receptors in the endocannabinoid system. This compound exhibits biological activity that may influence numerous physiological processes, including pain modulation and anti-inflammatory effects. It is utilized in preclinical research to explore therapeutic applications related to cannabinoid signaling pathways and their potential impact on various health conditions. -
MMB-CHMICA Metabolite
MMB-ICA is a metabolite of MMB-CHMICA, primarily targeting the cannabinoid receptor system. This compound demonstrates significant biological activity in modulating receptor signaling pathways, making it valuable for research in cannabinoid pharmacology. MMB-ICA is utilized in studies investigating the therapeutic potential of cannabinoids and their metabolic pathways. -
PB-22 Metabolite
PB-22 N-(5-Hydroxypentyl)-3-carboxyindole metabolite is a primary metabolite of the cannabinoid PB-22. This compound exhibits biological activity through its interaction with the endocannabinoid system, influencing cannabinoid receptor signaling pathways. It is utilized in research to explore the metabolic pathways of synthetic cannabinoids and their pharmacological effects in various biological systems. -
PB-22 Metabolite
PB-22 N-(4-Hydroxypentyl)-3-carboxyindole metabolite is a significant metabolite of the synthetic cannabinoid PB-22. This compound interacts primarily with cannabinoid receptors, influencing cannabinoid signaling pathways. It is valuable for research applications focused on studying the metabolism and pharmacological effects of cannabinoids, as well as providing insights into potential therapeutic uses and regulatory impacts associated with cannabinoid exposure. -
MMB-CHMICA Metabolite
AB-INACA is a metabolite of the synthetic cannabinoid AB-CHMINACA, acting primarily on the cannabinoid receptors. This compound has been utilized in research to investigate synthetic cannabinoid metabolism and receptor interaction dynamics. Its biological activity provides valuable insights into the pharmacological pathways of synthetic cannabinoids, making it a useful tool for toxicological studies and drug metabolism research. -
TRP Channel Inhibitor
Cannabidiorcol (CBDO) is an inhibitor of transient receptor potential (TRP) channels. This compound, structurally related to cannabidiol with a shortened pentyl side chain, exhibits anti-inflammatory properties while displaying low affinity for cannabinoid receptors. Research applications include investigations into its potential role in modulating inflammation and exploring its effects on tumorigenesis at elevated concentrations. -
ACU Inhibitor/VR1 Agonist
OMDM-5 is a selective anandamide cellular uptake (ACU) inhibitor, exhibiting a Ki of 4.8 μM. In addition, OMDM-5 demonstrates potent activity as a vanilloid receptor type 1 (VR1, TRPV1) agonist, with an EC50 of 75 nM. This compound also shows weak activity as a cannabinoid receptor type 1 (CB1) ligand, with a Ki of 4.9 μM. Its properties make OMDM-5 useful for studies involving pain modulation and endocannabinoid signaling pathways. -
Aminoalkylindole Derivative
7'-Methoxy NABUTIE is a derivative of aminoalkylindole that primarily targets cannabinoid receptors. This compound is recognized for its potential biological activity in modulating the effects associated with alcohol consumption. Research applications include investigations into the pathways of alcohol abuse and the exploration of therapeutic strategies for addiction. -
Tetrahydrocannabinol Analogues
8-Oxo-Δ9-THC is an oxygenated analog of tetrahydrocannabinol that exhibits significant interaction with cannabinoid receptors in the endocannabinoid system. This compound demonstrates notable biological activity, which may influence various cellular signaling pathways involved in pain modulation, inflammation, and neuroprotection. Its potential applications include research into therapeutic effects associated with cannabinoid compounds as well as studies investigating the pharmacological properties of cannabis-derived substances. -
Drug Derivative
1(R)-Tetrahydrocannabidiol is a drug derivative known for its interaction with cannabinoid receptors. It exhibits potential neuroprotective activity, making it a valuable tool for investigating neurological diseases and disorders. This compound facilitates research into the therapeutic effects of cannabinoids in various neurobiological contexts. -
Synthetic Cannabinoid
5-Fluoropentylindole serves as a synthetic cannabinoid that primarily targets cannabinoid receptors in the central nervous system. This compound exhibits significant affinity for CB1 receptors, making it a valuable tool for studying the endocannabinoid system and its associated signaling pathways. 5-Fluoropentylindole is applicable in pharmacological research and may aid in investigating the effects of synthetic cannabinoids on physiological processes and potential therapeutic outcomes. -
Lipid
N-Oleoyl-L-serine sodium is an analog of anandamide that primarily targets lipid signaling pathways. This compound exhibits notable biological activity as a cannabinoid receptor modulator, influencing physiological processes such as pain perception and inflammation. It is frequently used in research applications focused on neurobiology and lipid metabolism. -
Ester Product
(9Z,11E)-Octadecadien ethanolamide is an ester product that serves as a bioactive lipid mediator. It is known to modulate endocannabinoid receptor activity and influences various physiological processes, including pain perception and inflammation. This compound is primarily utilized in research focused on lipid signaling pathways, cannabinoid receptor studies, and neurobiology. -
Biochemical Assay Reagent
NBD AEA is a fluorescent derivative of anandamide (arachidonoylethanolamide) designed for use as a biochemical assay reagent. This compound serves as a valuable tool for studying cannabinoid receptors and endocannabinoid signaling pathways. It enables the visualization and quantification of AEA interactions in various biological systems, facilitating research in pharmacology and neurobiology. -
Phytocannabinoid
Δ9-Tetrahydrocannabivarinic acid (THCVA) is a phytocannabinoid that acts primarily on cannabinoid receptors, influencing various physiological processes. It exhibits potential anti-inflammatory properties and may play a role in modulating appetite and pain perception. THCVA is of interest in research relating to the therapeutic applications of cannabinoids in treating metabolic disorders and neurological conditions. -
Tetrahydrocannabinol Derivative
Δ9-THC-Ethyl is a derivative of Tetrahydrocannabinol (THC) featuring an ethyl chain modification. This compound primarily targets cannabinoid receptors and exhibits significant psychoactive properties. It is used in research to explore the pharmacological effects of cannabinoids, their therapeutic potential, and to study their role in various physiological processes. -
AEA Prodrug Analog
R-1 Methanandamide Phosphate is a water-soluble prodrug analog of arachidonylethanolamide (AEA), which acts primarily on cannabinoid receptors. This compound exhibits biological activity by enhancing the effects of endocannabinoids, providing insights into cannabinoid signaling pathways. It is suitable for research applications involving the study of the endocannabinoid system and its role in various physiological processes. -
Active Molecule
WAY-604603 is an active molecule that functions primarily as an allosteric modulator of the cannabinoid receptor 1 (CB1). It has demonstrated potential in influencing appetite regulation and neuroprotection. This compound is utilized in research exploring the endocannabinoid system and its implications in metabolic disorders and CNS functions. -
Phytocannabinoids Derivative
Cannabigerol monomethyl ether is a monomethyl ether derivative of the phytocannabinoid, cannabigerol. It exhibits potential biological activity by modulating cannabinoid receptors, thereby influencing a variety of physiological processes. This compound is suitable for research applications focusing on the endocannabinoid system, pharmacological studies of cannabinoids, and elucidation of their therapeutic effects. -
Active Molecule
WAY-271999 is an active molecule that serves as a potent antagonist of the cannabinoid receptor type 1 (CB1). It exhibits significant modulation of neuropsychiatric and metabolic processes, making it a valuable tool for research in obesity, addiction, and mood disorders. This compound is suitable for in vitro and in vivo studies aimed at elucidating the role of CB1 signaling in various physiological and pathological conditions. -
Cannabinoid Compound
Δ8-THCO (delta 8-tetrahydrocannabinol) is a cannabinoid compound derived from Cannabis sativa. This compound exhibits psychoactive properties akin to delta-9-THC, engaging with the CB1 cannabinoid receptor, which is implicated in various physiological processes such as appetite, pain sensation, and mood regulation. Δ8-THCO is utilized in research focused on understanding the effects of cannabinoids on the endocannabinoid system and exploring potential therapeutic applications in pain management and anxiety treatment. -
Endogenous Metabolite
Palmitoleoyl ethanolamide (POEA) is an endogenous fatty amide that functions primarily as a signaling molecule through the activation of cannabinoid receptors. It has been shown to exhibit anti-inflammatory and analgesic properties, making it relevant for research in pain management and inflammatory disorders. POEA's involvement in metabolic processes also positions it as a valuable target for studies in obesity and metabolic syndrome. -
N-acylserinol Compound
Myristoyl ethanolamide, an N-acylserinol compound, functions as a bioactive lipid signaling molecule. It is involved in modulating various biological processes, including inflammation and pain perception. Myristoyl ethanolamide serves as a valuable tool in research applications focused on lipid metabolism, neuromodulation, and the study of cannabinoid receptor interactions. This compound can enhance the understanding of endocannabinoid signaling pathways and their implications in physiological and pathological conditions. -
2-arachidonoylglycerol derivative
1-Monoarachidin is a 2-arachidonoylglycerol derivative that primarily acts as a modulator of cannabinoid receptors. This fatty acid plays a crucial role in the endocannabinoid system, contributing to various biological processes such as inflammation and neuroprotection. It is utilized in research to investigate the physiological effects of endocannabinoids and their potential therapeutic applications in neurological and inflammatory disorders. -
O-Alkyl-N-acyloxy Homologues
Oxy-Arachidonoyl ethanolamide is an O-alkyl-N-acyl oxime derivative that acts on O-Alkyl-N-acyl homologues. This compound exhibits significant biological activity, particularly in the modulation of endocannabinoid systems. It is employed in research applications focusing on cannabinoid receptor signaling, lipid metabolism, and neuroprotective studies, illuminating potential therapeutic pathways for various neurological diseases. -
Endogenous Metabolite
N-Methylarachidonamide is an analog of the endogenous cannabinoid anandamide, primarily targeting the central cannabinoid receptor (CB1). This compound exhibits a binding affinity with a Ki value of 60 nM for CB1, influencing various physiological processes. Additionally, it effectively inhibits rat glial gap junction cell-cell communication by 100% at a concentration of 50 μM. As such, N-Methylarachidonamide is a valuable tool for research exploring cannabinoid receptor signaling and its implications in neurobiology and related fields. -
FAAH Inhibitor
3-Decyl-5,5'-diphenyl-2-thioxo-4-imidazolidinone is a potent inhibitor of fatty acid amide hydrolase (FAAH) with a pI50 of 5.89. This compound exhibits significant activity against endocannabinoids and lipid mediators, making it relevant for studies in pain management, inflammation, and cannabinoid signaling pathways. Its limited affinity for cannabinoid receptors CB(1) and CB(2) allows for targeted research into FAAH-related physiological processes without direct receptor modulation. -
MAGL Inhibitor
OMDM169 is a selective inhibitor of monoacylglycerol lipase (MAGL), effectively increasing the levels of 2-arachidonoylglycerol (2-AG) in biological systems. This compound demonstrates significant analgesic properties through the indirect activation of cannabinoid receptors. OMDM169 exhibits an effective concentration of 0.13 μM, making it a valuable tool for research focused on pain modulation and cannabinoid receptor signaling pathways. -
Opioid Receptor
1-(5-Fluoropentyl)-1H-indazole-3-carboxylic acid is a selective modulator of opioid receptors. This compound exhibits significant affinity for cannabinoid receptor sites and shows potential in studying the therapeutic effects of cannabinoid modulation. It is primarily used in research exploring the pharmacological effects of synthetic cannabinoids and their metabolites. -
GPR55 Ligand
L-α-lysophosphatidylinositol (Soy) sodium is a potent endogenous ligand for the GPR55 receptor. As a lysophospholipid and endocannabinoid neurotransmitter, it plays a crucial role in various signaling pathways. It is primarily utilized in research applications focusing on cannabinoid receptor modulation, cell signaling processes, and neurobiology studies. -
Lipid
(−)-11-hydroxy-Δ8-THC is a phytocannabinoid that acts primarily as a cannabinoid receptor inhibitor. This compound exhibits significant biological activity in modulating lipid signaling pathways. It is utilized in research applications focused on neuropharmacology and the therapeutic potential of cannabinoids in various medical conditions.
-
Stable Isotope
N-Pentylindole-d11 is a deuterated analogue of 1-Pentyl-1H-indole, serving as a stable isotope. This compound is particularly valuable in pharmacokinetic studies, as it aids in tracing the metabolic pathways of indole-based compounds. Its application extends to the analysis of drug metabolism and the study of cannabinoid receptors, enhancing the understanding of biological mechanisms in related research fields. -
Isomer of 5-Fluoro PB-22
5-Fluoro PB-22 6-hydroxyisoquinoline isomer is a structural isomer of the synthetic cannabinoid 5-Fluoro PB-22, acting primarily as a cannabinoid receptor agonist. This compound exhibits significant binding affinity for CB1 and CB2 receptors, contributing to its potential biological effects. It can be utilized in research applications aimed at investigating the biochemical pathways and pharmacological effects of synthetic cannabinoids.
